DOI QR코드

DOI QR Code

Lack of Prognostic Impact of Adjuvant Radiation on Oncologic Outcomes in Elderly Women with Breast Cancer

  • Omidvari, Shapour ;
  • Talei, Abdolrasoul ;
  • Tahmasebi, Sedigheh ;
  • Moaddabshoar, Leila ;
  • Dayani, Maliheh ;
  • Mosalaei, Ahmad ;
  • Ahmadloo, Niloofar ;
  • Ansari, Mansour ;
  • Mohammadianpanah, Mohammad
  • Published : 2015.12.03

Abstract

Background: Radiotherapy plays an important role as adjuvant treatment in locally advanced breast cancer and in those patients who have undergone breast-conserving surgery. This study aimed to investigate the prognostic impact of adjuvant radiation on oncologic outcomes in elderly women with breast cancer. Materials and Methods: In this retrospective study, we reviewed and analyzed the characteristics, treatment outcome and survival of elderly women (aged ${\geq}60years$) with breast cancer who were treated and followed-up between 1993 and 2014. The median follow up for the surviving patients was 38 (range 3-207) months. Results: One hundred and seventy-eight patients with a median age of 74 (range 60-95) years were enrolled in the study. Of the total, 60 patients received postoperative adjuvant radiation (radiation group) and the remaining 118 did not (control group). Patients in the radiation group were significantly younger than those in the control group (P value=0.004). In addition, patients in radiation group had higher node stage (P value<0.001) and disease stage (P=0.003) and tended to have higher tumor grade (P=0.031) and received more frequent (P value<0.001) adjuvant and neoadjuvant chemotherapy compared to those in the control group. There was no statistically significant difference between two groups regarding the local control, disease-free survival and overall survival rates. Conclusions: In this study, we did not find a prognostic impact for adjuvant radiation on oncologic outcomes in elderly women with breast cancer.

Keywords

Elderly women;breast cancer;adjuvant radiation;prognosis;survival

References

  1. Dalberg K, Johansson H, Johansson U, et al (1998). A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast-conserving surgery. stockholm breast cancer study group. Cancer, 82, 2204-11. https://doi.org/10.1002/(SICI)1097-0142(19980601)82:11<2204::AID-CNCR15>3.0.CO;2-Y
  2. Darby SC, Ewertz M, McGale P, et al (2013). Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med, 368, 987-98. https://doi.org/10.1056/NEJMoa1209825
  3. Fisher B, Bryant J, Dignam JJ, et al (2002). Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol, 20, 4141-9. https://doi.org/10.1200/JCO.2002.11.101
  4. Fisher B, Dignam J, Bryant J, et al (1996a). Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst, 88, 1529-42. https://doi.org/10.1093/jnci/88.21.1529
  5. Fisher B, Dignam J, Mamounas EP, et al (1996b). Sequential methotrexate and fluorouracil for the treatment of nodenegative breast cancer patients with estrogen receptornegative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil. J Clin Oncol, 14, 1982-92. https://doi.org/10.1200/JCO.1996.14.7.1982
  6. Fyles AW, McCready DR, Manchul LA, et al (2004). Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med, 351, 963-70. https://doi.org/10.1056/NEJMoa040595
  7. Guan H, Dong YL, Ding LJ, et al (2015). Morphological factors and cardiac doses in whole breast radiation for left-sided breast cancer. Asian Pac J Cancer Prev, 16, 2889-94. https://doi.org/10.7314/APJCP.2015.16.7.2889
  8. Hughes KS, Schnaper LA, Bellon JR, et al (2013). Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol, 31, 2382-7. https://doi.org/10.1200/JCO.2012.45.2615
  9. Hughes KS, Schnaper LA, Berry D, et al (2004). Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med, 351, 971-7. https://doi.org/10.1056/NEJMoa040587
  10. McGuire SE, Gonzalez-Angulo AM, Huang EH, et al (2007). Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys, 68, 1004-9. https://doi.org/10.1016/j.ijrobp.2007.01.023
  11. Oran ES, Yankol Y, Soybir GR, et al (2014). Distinct postsurgical management in young and elderly breast cancer patients results in equal survival rates. Asian Pac J Cancer Prev, 15, 7843-7. https://doi.org/10.7314/APJCP.2014.15.18.7843
  12. Palta M, Palta P, Bhavsar NA, et al (2015). The use of adjuvant radiotherapy in elderly patients with early-stage breast cancer: changes in practice patterns after publication of cancer and leukemia group B 9343. Cancer, 121, 188-93. https://doi.org/10.1002/cncr.28937
  13. Phua CE, Bustam AZ, Yip CH, et al (2010). Prognostic factors for elderly breast cancer patients in University Malaya Medical Centre, Malaysia. Asian Pac J Cancer Prev, 11, 1205-11.
  14. Potter R, Gnant M, Kwasny W, et al (2007). Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer. Int J Radiat Oncol Biol Phys, 68, 334-40. https://doi.org/10.1016/j.ijrobp.2006.12.045
  15. Rutter CE, Lester-Coll NH, Mancini BR, et al (2015). The evolving role of adjuvant radiotherapy for elderly women with early-stage breast cancer. Cancer.
  16. Tinterri C, Gatzemeier W, Zanini V, et al (2009). Conservative surgery with and without radiotherapy in elderly patients with early-stage breast cancer: a prospective randomised multicentre trial. Breast, 18, 373-7. https://doi.org/10.1016/j.breast.2009.09.013
  17. Vrana D, Gatek J, Lukesova L, et al (2014). Omission of adjuvant radiation therapy in elderly patients with low risk breast cancer undergoing breast-conserving surgery--two center experience. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 158, 461-4. https://doi.org/10.5507/bp.2013.032
  18. Wang SL, Li YX, Song YW, et al (2009). [Postmastectomy radiotherapy in moderate-and high-risk elderly breast cancer patients]. Zhonghua Zhong Liu Za Zhi, 31, 863-6.
  19. Winzer KJ, Sauerbrei W, Braun M, et al (2010). Radiation therapy and tamoxifen after breast-conserving surgery: updated results of a 2 x 2 randomised clinical trial in patients with low risk of recurrence. Eur J Cancer, 46, 95-101. https://doi.org/10.1016/j.ejca.2009.10.007
  20. Yancik R, Wesley MN, Ries LA, et al (2001). Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA, 285, 885-92. https://doi.org/10.1001/jama.285.7.885
  21. Yavas G, Yavas C, Akyurek N (2013). Postmastectomy radiation therapy in locally advanced breast cancer. Exp Oncol, 35, 258-66.
  22. Zhou P, Recht A (2004). Young age and outcome for women with early-stage invasive breast carcinoma. Cancer, 101, 1264-74. https://doi.org/10.1002/cncr.20523